Skip to main content
Top
Published in: Reactions Weekly 1/2020

01-07-2020 | Polyneuropathy | Case report

Panitumumab

Acquired drug resistance, polyneuropathy and cutaneous toxicity: case report

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Aguilar S, et al. RNF43- And NOTCH1-mutated chemotherapy and Anti-EGFR-refractory colorectal cancer: Should clonality guide target prioritization with investigational therapies?. JCO Precision Oncology 3: no pagination, Jan 2019. Available from: URL: http://doi.org/10.1200/PO.19.00182 Aguilar S, et al. RNF43- And NOTCH1-mutated chemotherapy and Anti-EGFR-refractory colorectal cancer: Should clonality guide target prioritization with investigational therapies?. JCO Precision Oncology 3: no pagination, Jan 2019. Available from: URL: http://​doi.​org/​10.​1200/​PO.​19.​00182
Metadata
Title
Panitumumab
Acquired drug resistance, polyneuropathy and cutaneous toxicity: case report
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80943-z

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Adalimumab

Case report

Benidipine

Case report

Cidofovir